USE OF THROMBIN INHIBITORS FOR THE INHIBITION OF OCULAR FIBRIN FORMATION

摘要

of the disclosure The use of thrombin inhibitors for the inhibition of ocular fibrin formation The use of substances which are able to inhibit the activity of soluble and fibrin- and cell-bound thrombin, in particular hirudin, its derivatives, peptides derived therefrom and low molecular weight thrombin inhibitors in a process for the preparation of a pharmaceutical for the inhibition of ocular fibrin formation and deposition is described.